Merck & Co. Investment Purchases decreased by 38.9% to $374.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.1%, from $595.00M to $374.00M. Over 2 years (FY 2021 to FY 2024), Investment Purchases shows an upward trend with a 2178.2% CAGR.
An increase may indicate a strategy to earn interest on excess cash, while a decrease may suggest a need for cash for operations or debt repayment.
This metric captures the cash outflow for the purchase of marketable securities, such as stocks, bonds, or other financi...
Standard for large-cap companies with significant cash reserves; peers manage these portfolios to balance liquidity needs with yield generation.
purchases_of_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $250.00K | $250.00K | $250.00K | $494.00M | $562.00M | $25.00M | $117.00M | $251.00M | $15.00M | $49.00M | $0.00 | $455.00M | $595.00M | $612.00M | $374.00M |
| QoQ Change | — | +0.0% | +0.0% | >999% | +13.8% | -95.6% | +368.0% | +114.5% | -94.0% | +226.7% | -100.0% | — | +30.8% | +2.9% | -38.9% |
| YoY Change | — | — | — | >999% | — | — | — | -49.2% | -97.3% | +96.0% | -100.0% | +81.3% | >999% | >999% | -37.1% |